Dr. John P Lazenby, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3320 Old Jefferson Rd, Ste 200a, Athens, GA 30607 Phone: 706-549-5560 Fax: 706-543-2593 |
Dr. Jane M Parks, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3320 Old Jefferson Rd, Ste 200a, Athens, GA 30607 Phone: 706-549-5560 Fax: 706-543-2593 |
Dr. Thomas Jason Martin, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3320 Old Jefferson Rd, Suite 200a, Athens, GA 30607 Phone: 706-549-5560 Fax: 706-353-0636 |
Dr. Stephen K Lucas, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3320 Old Jefferson Rd, Suite 200a, Athens, GA 30607 Phone: 706-549-5560 Fax: 706-543-2593 |
Dr. Francis Hugh Jenkins, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3320 Old Jefferson Rd, Suite 200a, Athens, GA 30607 Phone: 706-549-5560 Fax: 706-543-2593 |
Dr. Shraddha Tongia, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3320 Old Jefferson Rd, Building 200, Suite A, Athens, GA 30607 Phone: 706-549-5560 Fax: 706-543-2593 |
Justin Philip Clack, PA Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 242 King Ave Ste 130, Athens, GA 30606 Phone: 706-613-5880 |
Milos Tucakovic, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3320 Old Jefferson Road, Bldg 200 Ste A, Athens, GA 30607 Phone: 706-549-5560 Fax: 706-353-0636 |
News Archive
Now a new supercooling technique for human organs promises to extend the period from the moment of removal to 1.5 days rather than just a few hours. This provides a useful window of time within which transplant teams and patients can hope to get a viable organ.
A form of artificial intelligence designed to interpret a combination of retinal images was able to successfully identify a group of patients who were known to have Alzheimer's disease, suggesting the approach could one day be used as a predictive tool, according to an interdisciplinary study from Duke University.
Pulmo BioTech Inc. has announced that it will ultimately receive at least $3.3 million pursuant to the license agreement contemplated by the previously announced non-binding letter of intent with Biotechnology Consulting Poland Sp. z.o.o. with respect to its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) development work, clinical trials and ultimately, commercialization in the European market.
Listen to the political rhetoric around the contraception mandate, and you might think that employers must provide women with free birth control of every kind. It's not quite that simple.
› Verified 1 days ago